Brain Blend is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains Dihexa (10 mg), Tesofensine (250 mcg), and BPC-157 (125 mcg), with 60 tablets per container. Batch-specific Certificates of Analysis document compound identities, per-unit content, physical form, and relevant excipient information to support reproducibility and documentation control.

This formulation is evaluated in controlled in-vitro research systems investigating multi-target signaling. These include neuroactive pathway models, energy-balance-related neurotransmitter systems, peptide-mediated cell-communication networks, and complex assay-based pathway mapping.

This multi-analyte formulation is characterized for use in analytical and cell-based models examining concentration-response relationships, receptor and transporter engagement, downstream signaling cascades, and interaction networks among neuroactive and peptide pathways. Applications include comparative pathway profiling, assay development, and systems-level mapping of molecular feedback loops under controlled laboratory conditions.

Each production lot is qualified at 99%+ purity using high-performance liquid chromatography, with compound identity confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytics. Manufacturing documentation, including Certificates of Analysis, raw-material provenance, and batch records, is maintained to support traceability, institutional procurement review, and audit readiness.

• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use